The association of serum prolidase activity with developmental dysplasia of the hip

N Soran1, O Altindag, N Aksoy

  • 1Department of Physical Medicine and Rehabilitation, Research Hospital, Harran University, Sanliurfa, Turkey.

Insights

Serum prolidase activity was significantly higher in patients with developmental dysplasia of the hip (DDH). This suggests increased collagen turnover may contribute to DDH development and progression.

Area of Science:

  • Biochemistry
  • Orthopedics
  • Pediatric Medicine

Background:

  • Developmental dysplasia of the hip (DDH) is a common pediatric orthopedic condition.
  • The exact etiopathogenesis of DDH remains incompletely understood.
  • Collagen metabolism is crucial for hip joint development and stability.

Purpose of the Study:

  • To investigate serum prolidase activity as a potential biomarker in patients with DDH.
  • To explore the relationship between prolidase activity and the severity of hip dysplasia.
  • To assess the role of collagen turnover in the pathogenesis of DDH.

Main Methods:

  • Serum samples were collected from patients diagnosed with DDH and healthy controls.
  • Prolidase enzyme activity was quantified using a spectrophotometric assay.
  • Statistical analysis was performed to compare enzyme activity between groups and correlate it with dysplasia severity.

Main Results:

  • Patients with DDH exhibited significantly elevated serum prolidase activity compared to the control group (p = 0.002).
  • A positive correlation was observed between serum prolidase levels and the degree of hip dysplasia.
  • These findings indicate altered collagen metabolism in individuals with DDH.

Conclusions:

  • Elevated serum prolidase activity is associated with the presence and severity of DDH.
  • Increased collagen turnover, as indicated by prolidase activity, may play a role in the etiopathogenesis and progression of DDH.
  • Serum prolidase activity could serve as a potential indicator for collagen metabolism disturbances in DDH.